Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2022-01-26 00:00:00 ET · period of report 2022-01-24 · accession 0001567619-22-001778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-26 | 2022-01-24 | RIGL | VANCE DOLLY | GC, EVP Corp. Affairs, Sect | A - Grant | $0.00 | +50.0K | 60.3K | +487% | $0 |
| D | 2022-01-26 | 2022-01-24 | RIGL | VANCE DOLLY | GC, EVP Corp. Affairs, Sect | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-24 | A | A | 50,000 | $0.00 | 60,260 | D | — | — | (F1) The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2022, with the first annual vest occurring on February 1, 2023. (F2) Includes 9,685 shares acquired under the Issuer's stock purchase plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-24 | A | A | 100,000 | $0.00 | 100,000 | D | $2.42 · — to 2032-01-24 | 100,000 Common Stock | (F3) The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the reporting person's continuous service to the issuer through each such period. |